Metacognitive Training for Negative Symptoms in Schizophrenia
Metacognitive Training for Negative Symptoms (MCT Minus)
This study is testing if a new training program can help people with schizophrenia feel less withdrawn and more engaged in life compared to regular counseling.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sormland County Council, Sweden Academic / other |
| Locations | 1 site (Multiple Locations) |
| Trial ID | NCT06127004 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Metacognitive Training (MCT) Minus, specifically designed to address negative symptoms in individuals with schizophrenia and related disorders. Unlike traditional approaches that focus on positive symptoms, this intervention aims to reduce persistent negative symptoms such as social withdrawal and avolition. The study will assess the impact of MCT Minus on patients' functioning and symptomatology, providing a scientific basis for its efficacy. Participants will receive either MCT Minus or supportive counseling as part of the intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 with a clinical diagnosis of schizophrenia, delusional disorder, or non-affective psychosis residing in specific regions of Sweden.
Not a fit: Patients with severe organic brain dysfunction, learning disabilities, or those unable to communicate in Swedish may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients suffering from negative symptoms of schizophrenia.
How similar studies have performed: While there is limited research specifically on MCT Minus for negative symptoms, the need for effective interventions targeting these symptoms has been recognized, indicating potential for success in this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over the age of 18 * Clinical diagnosis of schizophrenia, delusional disorder or non-affective psychosis * Resident in Region Sörmland, Region Västmanland or Region Uppland Exclusion Criteria: * Evidence of severe organic brain dysfunction * Learning disabilities * Difficulty with the Swedish language * Visual and/or hearing impairment * Being unable or unwilling to provide written informed consent
Where this trial is running
Multiple Locations
- Region Sörmland — Multiple Locations, Sweden (Recruiting)
Study contacts
- Principal investigator: Linda Swanson, Dr — Region Sörmland/ Uppsala University
- Study coordinator: Linda Swanson, Dr
- Email: linda.swanson@regionsormland.se
- Phone: 0046-720 843 708
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.